Clinical characteristics of patients with chronic hepatitis B who developed genotypic resistance to entecavir: Real-life experience
Hong Joo Kim, Yong Kyun Cho, Woo Kyu Jeon, Byung Ik Kim
Clin Mol Hepatol. 2017;23(4):323-330.   Published online 2017 Sep 5     DOI:
Citations to this article as recorded by Crossref logo
Current state-of-the-art pharmacotherapy for the management of hepatitis B infection
Hans L. Tillmann, Gbeminiyi Samuel
Expert Opinion on Pharmacotherapy.2019; 20(7): 873.     CrossRef
Reactions Weekly.2018; 1688(1): 98.     CrossRef
Is it possible to predict the development of an entecavir resistance mutation in patients with chronic hepatitis B in clinical practice?
Joon Yeul Nam, Jeong-Hoon Lee
Clinical and Molecular Hepatology.2017; 23(4): 311.     CrossRef